A Word from President and CEO, Jason Dvorak

Learn about the HomECG+ technology and how it benefits both patients and providers from President and CEO of Lohman Technologies, Jason Dvorak.

The HomECG+ is indicated for self-testing by patients who have been diagnosed with or are susceptible to developing atrial fibrillation and who would like to monitor and record their heart rhythms on an intermittent basis.